lisinopril and Chest-Pain

Topics: Adult; Antihypertensive Agents; Aspirin; Chest Pain; Coronary Vasospasm; Dyspnea; Humans; Lisinopril; Male; Marijuana Smoking; Metoprolol; Muscle Tonus; Rivaroxaban; Tobacco Smoking; Treatment Outcome; Young Adult

Topics: Adult; Antihypertensive Agents; Chest Pain; Diagnosis, Differential; Diuretics; Electrocardiography; Fever; Furosemide; Humans; Lisinopril; Male; Metoprolol; Myocardial Infarction; Myocarditis; Stroke Volume; Systemic Inflammatory Response Syndrome; Treatment Outcome; Troponin I; West Nile Fever; West Nile virus

Aim of the study was to assess influence of long-term therapy with angiotensin converting enzyme inhibitor lisinopril on morphofunctional parameters of the left ventricle (LV) and painless myocardial ischemia in 109 premenopausal women with stage II hypertension depending on functional state of peripheral artery endothelium. The results show that lisinopril therapy in premenopausal women with hypertension can stop or even cause regression of LV myocardial hypertrophy and produce favorable effect on LV remodeling mostly in women with concentric type of hypertrophy and/or without endothelial dysfunction, and has positive effect on frequency of painless myocardial ischemia events.

Topics: Angiotensin-Converting Enzyme Inhibitors; Chest Pain; Electrocardiography, Ambulatory; Endothelium, Vascular; Female; Follow-Up Studies; Humans; Hypertension; Lisinopril; Middle Aged; Myocardial Ischemia; Premenopause; Radial Artery; Time Factors; Treatment Outcome; Vasodilation; Ventricular Remodeling